Clinical Trials on Skin and Connective Tissue Disease

Total 356176 results

Repros Therapeutics Inc.

Terminated

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States, Mexico
Repros Therapeutics Inc.

Terminated

Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States
Meharry Medical College

Terminated

Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids

Leiomyoma

United States
Taipei Veterans General Hospital, Taiwan

Unknown

The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids

Uterine Fibroids

Taiwan
Mediterranea Medica S. L.

Completed

Mifepristone for Treatment of Uterine Fibroids (Mifemyo)

Uterine Fibroids

Cuba
Imperial College London
InSightec-TxSonics

Completed

Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids

Uterine Fibroids

United Kingdom
Ankara University

Completed

MIYOPERİCYTOMA OF ORAL MUCOSE: CASE REPORT

Myopericytoma

Turkey
Endo Pharmaceuticals

Recruiting

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) (STRIDE)

Ledderhose Disease | Plantar Fibromatosis

United States
Zagazig University

Not yet recruiting

Low-Dose Enoxaparin in Psoriasis

Psoriasis
Neil Korman

Recruiting

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

Psoriasis

United States
Ganzhou Hemay Pharmaceutical Co., Ltd

Not yet recruiting

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Psoriasis
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A Study of QY101 Ointment in Subjects With Plaque Psoriasis

Psoriasis

China
Hansoh BioMedical R&D Company

Recruiting

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Psoriasis

China
Sanofi

Recruiting

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis (SPECIFI-PSO)

Psoriasis

Chile, Germany, Mauritius, Japan, Canada, United States, Georgia, Turkey, Spain, Czechia, Hungary, Poland, Portugal, United Kingdom, China, Argentina
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Psoriasis

China
Gaia AG
University of Giessen; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Effectiveness of a Digital Health Application for Psoriasis

Psoriasis

Germany
First Hospital of China Medical University
China-Japan Friendship Hospital

Not yet recruiting

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

Psoriasis

China
Bristol-Myers Squibb

Recruiting

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis (RePhlect)

Psoriasis

United States
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Psoriasis

Bulgaria, Romania, Moldova, Republic of, Georgia
SFA Therapeutics

Recruiting

Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques

Psoriasis

United States
AbbVie

Recruiting

Effect of Long-term Psoriasis on Patients' Life - CORONATE (CORONATE)

Psoriasis

Italy
University Hospital, Ghent
Novartis; Janssen, LP; Vlerick Business School; Scientific Research Foundation-Flanders

Recruiting

Value Based Healthcare in Psoriasis (IRIS)

Psoriasis

Belgium
Peking University People's Hospital
Zhonghao Pharmaceutical

Recruiting

Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis

Psoriasis

China
Chinese University of Hong Kong

Recruiting

Chinese Medicine for Patients With Psoriasis

Psoriasis

Hong Kong
Universitaire Ziekenhuizen KU Leuven

Recruiting

ProspectIve Cohort psoriASiS fOllow-up (PICASSO) (PICASSO)

Psoriasis

Belgium
Institut Pasteur
Janssen Biotech, Inc.

Recruiting

Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis (Pso23)

Psoriasis

France
Peking University People's Hospital
Zhonghao Pharmaceutical

Recruiting

Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults

Psoriasis

China
Jaehwan Kim
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Recruiting

Risankizumab Long-term Remission Study

Psoriasis

United States
Bausch Health Americas, Inc.

Recruiting

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Psoriasis

United States
Janssen-Cilag International NV

Recruiting

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis (STELARA)

Psoriasis

Belgium, United Kingdom, Austria, Denmark, France, Germany, Netherlands, Norway, Russian Federation, Switzerland, Greece
Fundación Academia Española de Dermatología
Bristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; Novarti... and other collaborators

Recruiting

Spanish Registry of Systemic Treatments in Psoriasis (Biobadaderm)

Psoriasis

Spain
Amgen

Completed

Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain (APPROPIATE)

Psoriasis

Spain
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Psoriasis

United States, Australia, Canada, Japan, United Kingdom
Taizhou Mabtech Pharmaceutical Co.,Ltd

Completed

Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers

Psoriasis

China
Psoriasis Treatment Center of Central New Jersey

Completed

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey
Taro Pharmaceuticals USA

Completed

Topical Psoriasis Study for Patients Receiving Biologic Therapy

Psoriasis
Oregon Medical Research Center
AbbVie

Active, not recruiting

High Dose Risankizumab for Psoriasis (KNOCKOUT)

Psoriasis

United States
Northwestern University
Radboud University Medical Center; Children's Hospital of Philadelphia; National... and other collaborators

Active, not recruiting

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

Psoriasis

United States
Astellas Pharma Global Development, Inc.
Kyowa Kirin Co., Ltd.

Completed

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

Canada, Australia, New Zealand
Amgen

Completed

A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice (APPRECIATE)

Psoriasis

Austria, Germany, Switzerland, United Kingdom, Ireland, Spain, Croatia, Czechia, Slovenia, Sweden
Nektar Therapeutics
Eli Lilly and Company

Completed

A Study of LY3471851 in Participants With Psoriasis

Psoriasis

United States
Eli Lilly and Company

Completed

A Study of Mirikizumab in Participants With Plaque Psoriasis

Psoriasis

United States
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Assistance Publique - Hôpitaux de Paris
Société de Dermatologie Française

Completed

Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis (PSOBIOTEQ)

Psoriasis

France
Bristol-Myers Squibb

Completed

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

Psoriasis

China
AbbVie

Terminated

A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Psoriasis

United States, Canada, Japan
Bristol-Myers Squibb

Active, not recruiting

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (POETYK PSO-LTE)

Psoriasis

China, Taiwan, Spain, United States, Hungary, Canada, Germany, Japan, Australia, Poland, Czechia, United Kingdom, Korea, Republic of, Israel, New Zealand, Sweden, France, Finland, Russian Federation, Puerto Rico
Janssen-Cilag Ltd.

Terminated

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis (G-CARE)

Psoriasis

Italy, Germany, Greece
Universitas Sebelas Maret

Completed

The Disease Severity In Patients With Psoriasis

Psoriasis

Indonesia
AbbVie

Completed

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement (IMMprint)

Psoriasis

United States, Canada, Puerto Rico, Spain

3

Subscribe